Last reviewed: June 22, 2026

Last updated: June 22, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a GLP-1 receptor agonist originally developed to treat type 2 diabetes that has shown remarkable results for weight loss in clinical trials. Studies demonstrate that people taking semaglutide lose an average of 15% of their body weight over 68 weeks. PlexusDx delivers prescription-strength compounded semaglutide injections from licensed 503A pharmacies to help eligible patients achieve their weight loss goals without insurance requirements.

Who Is a Good Candidate for Semaglutide Injection

Semaglutide may be appropriate for adults with a BMI of 27 or higher who also have at least one weight-related health condition, or those with a BMI of 30 or higher regardless of other factors. Your medical history, current medications, and metabolic status all influence whether semaglutide is the right choice. PlexusDx requires a consultation with a licensed healthcare provider to assess your individual candidacy and ensure the medication aligns with your health profile.

People who have struggled with traditional diets and exercise alone often benefit from semaglutide's appetite-suppressing mechanism. The medication works by mimicking glucagon-like peptide-1, a hormone that signals fullness to your brain and slows stomach emptying. This dual action helps reduce food cravings and caloric intake naturally, making weight loss more sustainable for many patients.

Medical Conditions That May Make Semaglutide Right for You

If you have type 2 diabetes, prediabetes, or high blood pressure, semaglutide offers dual benefits by addressing both weight and metabolic health simultaneously. Patients with fatty liver disease, polycystic ovary syndrome (PCOS), or sleep apnea frequently see improvements beyond weight loss when treated with GLP-1 therapy. These comorbidities may indicate that semaglutide could provide meaningful health gains for your specific situation.

Semaglutide is not appropriate for individuals with a personal history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN2). Pregnancy, breastfeeding, and certain severe gastrointestinal disorders are also contraindications. PlexusDx requires a complete health history review to identify any factors that might make semaglutide unsafe for you.

How PlexusDx Semaglutide Differs From Branded Options

PlexusDx compounded semaglutide injections are manufactured by licensed 503A compounding pharmacies using pharmaceutical-grade ingredients, offering a more affordable alternative to brand-name Wegovy or Ozempic. While branded versions cost significantly more per dose, PlexusDx charges a flat monthly rate of $149 at the entry tier—your dose may need to go up, but your price won't. This pricing model removes the financial barrier many patients face when considering GLP-1 therapy.

Compounded medications undergo the same quality standards and ingredient sourcing as brand-name versions, though they are not FDA-approved in the same way. PlexusDx works exclusively with licensed compounding pharmacies to ensure purity, potency, and sterility. All patients receive dosing guidance and ongoing support from healthcare providers trained in GLP-1 therapy.

Genetic Testing to Personalize Your Semaglutide Response

Not everyone responds to semaglutide with the same weight loss or side effect profile, and genetics play a significant role in medication effectiveness. PlexusDx offers the Precision Peptide Genetic Test, a peptide-pathway genetic assessment that examines key variants including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313. These genetic markers influence how your body processes GLP-1 signals and manages appetite regulation, helping predict your likely response to semaglutide.

By mapping 14 metabolic pathways and 150+ genetic insights, the Precision Peptide Genetic Test can guide dose selection and identify whether semaglutide or alternative compounds like tirzepatide might be more effective for your genetic profile. This test is available as a $99 add-on after your first month of treatment, allowing PlexusDx to tailor your therapy based on your unique biology. Patients with specific genetic variants may achieve faster results or experience fewer side effects when matched to the right medication.

Getting Started With PlexusDx Semaglutide

Starting semaglutide with PlexusDx requires a simple online consultation with a licensed healthcare provider who will review your medical history, current medications, and weight loss goals. No insurance is required, and the service is available across all 50 states. If you qualify, your prescription is filled by a licensed 503A compounding pharmacy and shipped directly to your home with detailed injection instructions.

PlexusDx semaglutide injections are HSA- and FSA-eligible, making them accessible to patients with tax-advantaged health savings accounts. Your starting dose begins conservatively and adjusts based on your tolerance and results, typically increasing every 4 weeks until reaching your therapeutic dose. Throughout your treatment, PlexusDx providers monitor your progress and adjust your plan as needed to optimize weight loss and minimize side effects.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight can I expect to lose with semaglutide from PlexusDx?

Individual results vary, but clinical trials show average weight loss of 15% of starting body weight over 68 weeks, with some patients achieving 20% or more. Your genetics, diet, exercise, and adherence to the medication regimen all influence your outcome. PlexusDx providers track your progress monthly and adjust dosing to maximize your results safely.

Is compounded semaglutide from PlexusDx as safe as brand-name Wegovy?

Yes, PlexusDx compounded semaglutide comes from licensed 503A compounding pharmacies that follow the same quality standards as pharmaceutical manufacturers. The active ingredient is identical to brand-name formulations, though compounded versions are not FDA-approved in the traditional sense. All patients receive medical oversight and side effect monitoring from qualified healthcare providers.

Why does PlexusDx charge a flat monthly price instead of flat per-compound pricing?

PlexusDx uses a flat monthly rate ($149 starting) because your dose may need to go up during treatment, but your price won't increase. This transparent pricing model removes the financial uncertainty of dose-escalation ladders found with other providers. HSA and FSA funds can be used to cover these charges, making care even more affordable.

What if semaglutide doesn't work well for me or causes side effects?

PlexusDx offers alternative GLP-1 compounds including oral semaglutide, tirzepatide injection, and GLP-Squared dual-compound formulas if semaglutide alone is not ideal. The Precision Peptide Genetic Test can help identify whether your genetics predict better outcomes with a different medication. Your provider will work with you to find the most effective and tolerable option.

What does the PlexusDx Precision Peptide Genetic Test tell me?

The Precision Peptide Genetic Test analyzes peptide-pathway variants affecting appetite, metabolism, and GLP-1 receptor sensitivity. Results reveal your genetic predispositions for weight loss response and help predict which GLP-1 compound (semaglutide, tirzepatide, or dual therapy) may work best for your biology. At $99 as an add-on after your first treatment month, this test personalizes your therapy for faster, more predictable results.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves